4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-039055
Chief Development Officer sold 1,545 shares at an average $15.01 ($23,198)
- Chief Development Officer acquired 1,239 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Curley Joanne · Chief Development Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-22 | Exercise or conversion : show line 1 in the form | +1,239 | $6.37 | $7,896 | 25,233 | D |
| 2022-06-22 | Sale : show line 2 in the form | −1,239 | $15.01 | $18,603 | 23,994 | D |
| 2022-06-22 | Sale : show line 3 in the form | −306 | $15.02 | $4,595 | 23,688 | D |
| Open-market sales · 1,545 sh · avg $15.01 · $23,198 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-22 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −1,239 | 22,906 | D |
Loading xslF345X03/doc4.xml…